Oncotelic Therapeutics, Inc. SEC filings OTLC
Oncotelic Therapeutics, Inc. has 1,007 filings in SEC EDGAR's recent list, going back to Jul 19, 2005. Its latest annual report, Form 10-K, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 26, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| D | Filing | Jul 22, 2026 | — |
| NT 10-K | Filing | Mar 31, 2026 | Dec 31, 2025 |
| EFFECT | Filing | Dec 23, 2025 | — |
| CORRESP | Letter to the SEC | Dec 22, 2025 | — |
| D | Filing | Dec 11, 2025 | — |
| NT 10-Q | Filing | Nov 14, 2025 | Sep 30, 2025 |
| EFFECT | Filing | Apr 21, 2025 | — |
| NT 10-K | Filing | Mar 31, 2025 | Dec 31, 2024 |
| NT 10-Q | Filing | Nov 14, 2024 | Sep 30, 2024 |
| EFFECT | Filing | Apr 22, 2024 | — |
| NT 10-K | Filing | Apr 1, 2024 | Dec 31, 2023 |
| NT 10-Q | Filing | Aug 15, 2023 | Jun 30, 2023 |
| D | Filing | Jul 13, 2023 | — |
| NT 10-Q | Filing | May 15, 2023 | Mar 31, 2023 |
| EFFECT | Filing | Apr 25, 2023 | — |
| NT 10-K | Filing | Apr 3, 2023 | Dec 31, 2022 |
| NT 10-Q | Filing | Nov 14, 2022 | Sep 30, 2022 |
| NT 10-Q | Filing | Aug 15, 2022 | Jun 30, 2022 |
| NT 10-Q | Filing | May 16, 2022 | Mar 31, 2022 |
| EFFECT | Filing | May 6, 2022 | — |
| NT 10-K | Filing | Mar 31, 2022 | Dec 31, 2021 |
| NT 10-Q | Filing | Nov 15, 2021 | Sep 30, 2021 |
| EFFECT | Filing | Sep 9, 2021 | — |
| NT 10-Q | Filing | Aug 16, 2021 | Jun 30, 2021 |
| EFFECT | Filing | Jun 2, 2021 | — |
| CORRESP | Letter to the SEC | May 28, 2021 | — |
| UPLOAD | Letter from the SEC | May 27, 2021 | — |
| NT 10-Q | Filing | May 17, 2021 | Mar 31, 2021 |
| NT 10-K | Filing | Apr 1, 2021 | Dec 31, 2020 |
| D | Filing | Aug 4, 2020 | — |
| UPLOAD | Letter from the SEC | Jun 26, 2020 | — |
| PRER14A | Filing | May 20, 2020 | — |
| CORRESP | Letter to the SEC | May 19, 2020 | — |
| UPLOAD | Letter from the SEC | May 4, 2020 | — |
| PRER14A | Filing | Apr 17, 2020 | — |
| CORRESP | Letter to the SEC | Apr 13, 2020 | — |
| UPLOAD | Letter from the SEC | Nov 25, 2019 | — |
| PRER14A | Filing | Nov 18, 2019 | — |
| CORRESP | Letter to the SEC | Nov 18, 2019 | — |
| NT 10-Q | Filing | Nov 14, 2019 | Sep 30, 2019 |
| UPLOAD | Letter from the SEC | Oct 31, 2019 | — |
| NT 10-Q | Filing | Aug 15, 2019 | Jun 30, 2019 |
| PRER14C | Filing | Jun 13, 2019 | — |
| D | Filing | May 7, 2019 | — |
| D | Filing | May 7, 2019 | — |
| NT 10-K | Filing | Apr 2, 2019 | Dec 31, 2018 |
| EFFECT | Filing | Jun 26, 2018 | — |
| CORRESP | Letter to the SEC | Jun 25, 2018 | — |
| UPLOAD | Letter from the SEC | Jun 22, 2018 | — |
| RW | Filing | May 18, 2018 | — |
| D | Filing | Apr 25, 2018 | — |
| NT 10-K | Filing | Apr 2, 2018 | Dec 31, 2017 |
| 25-NSE | Delisting notice | Jan 25, 2017 | — |
| UPLOAD | Letter from the SEC | Sep 30, 2016 | — |
| CORRESP | Letter to the SEC | Sep 30, 2016 | — |
| CORRESP | Letter to the SEC | Sep 29, 2016 | — |
| UPLOAD | Letter from the SEC | Sep 27, 2016 | — |
| EFFECT | Filing | Jun 5, 2015 | — |
| CORRESP | Letter to the SEC | Jun 2, 2015 | — |
| UPLOAD | Letter from the SEC | Jun 2, 2015 | — |
| EFFECT | Filing | Jun 16, 2014 | — |
| CT ORDER | Filing | Apr 14, 2014 | — |
| EFFECT | Filing | Feb 11, 2014 | — |
| CORRESP | Letter to the SEC | Feb 11, 2014 | — |
| CORRESP | Letter to the SEC | Jan 31, 2014 | — |
| UPLOAD | Letter from the SEC | Jan 31, 2014 | — |
| EFFECT | Filing | Nov 13, 2013 | — |
| CORRESP | Letter to the SEC | Nov 12, 2013 | — |
| UPLOAD | Letter from the SEC | Oct 9, 2013 | — |
| UPLOAD | Letter from the SEC | Aug 15, 2013 | — |
| EFFECT | Filing | May 1, 2013 | — |
| EFFECT | Filing | Jun 14, 2012 | — |
| EFFECT | Filing | Apr 18, 2012 | — |
| EFFECT | Filing | Jan 11, 2012 | — |
| EFFECT | Filing | Jun 8, 2011 | — |
| UPLOAD | Letter from the SEC | Nov 19, 2010 | — |
| UPLOAD | Letter from the SEC | Nov 10, 2010 | — |
| CORRESP | Letter to the SEC | Nov 10, 2010 | — |
| UPLOAD | Letter from the SEC | Nov 9, 2010 | — |
| CORRESP | Letter to the SEC | Oct 15, 2010 | — |
| CORRESP | Letter to the SEC | Aug 9, 2010 | — |
| UPLOAD | Letter from the SEC | Aug 5, 2010 | — |
| EFFECT | Filing | Jun 16, 2010 | — |
| EFFECT | Filing | Apr 29, 2010 | — |
| CORRESP | Letter to the SEC | Apr 28, 2010 | — |
| CORRESP | Letter to the SEC | Apr 15, 2010 | — |
| UPLOAD | Letter from the SEC | Apr 6, 2010 | — |
| D | Filing | Mar 26, 2010 | — |
| EFFECT | Filing | Dec 21, 2009 | — |
| 425 | Filing | Dec 3, 2009 | — |
| 425 | Oxigene, inc. | Nov 20, 2009 | — |
| 425 | Filing | Nov 17, 2009 | — |
| 425 | Oxigene, inc. | Nov 10, 2009 | — |
| 425 | Oxigene, inc. | Nov 9, 2009 | — |
| 425 | Oxigene, inc. | Nov 9, 2009 | — |
| 425 | Oxigene, inc. | Oct 16, 2009 | — |
| 425 | Filing | Oct 15, 2009 | — |
| 425 | Filing | Oct 15, 2009 | — |
| EFFECT | Filing | Aug 25, 2009 | — |
| EFFECT | Filing | Aug 13, 2009 | — |
| CT ORDER | Filing | Jun 1, 2009 | — |
| UPLOAD | Letter from the SEC | Apr 6, 2009 | — |
| CORRESP | Letter to the SEC | Apr 3, 2009 | — |
| UPLOAD | Letter from the SEC | Apr 1, 2009 | — |
| EFFECT | Filing | Dec 1, 2008 | — |
| EFFECT | Filing | Dec 1, 2008 | — |
| CT ORDER | Filing | Nov 21, 2008 | — |
| DEFR14A | Oxigene, inc. | Nov 14, 2008 | — |
| REGDEX | Auto-generated paper document | Nov 4, 2008 | — |
| UPLOAD | Letter from the SEC | Oct 21, 2008 | — |
| CORRESP | Letter to the SEC | Oct 21, 2008 | — |
| UPLOAD | Letter from the SEC | Oct 17, 2008 | — |
| EFFECT | Filing | May 15, 2008 | — |
| RW | Oxigene, inc. request for withdrawal | May 2, 2008 | — |
| CORRESP | Letter to the SEC | Apr 25, 2008 | — |
| UPLOAD | Letter from the SEC | Apr 25, 2008 | — |
| UPLOAD | Letter from the SEC | Apr 24, 2008 | — |
Showing 117 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- OTLC (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Aguora Hills, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 908259
- Former names
- MATEON THERAPEUTICS INC (until Mar 26, 2021); OXIGENE INC (until Jun 3, 2016)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.